Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination

Sponsor
Louisiana State University Health Sciences Center Shreveport (Other)
Overall Status
Completed
CT.gov ID
NCT02897232
Collaborator
(none)
386
1
45
8.6

Study Details

Study Description

Brief Summary

This is a minimal risk, anonymous, convenience sample, social behavioral study using qualitative descriptive survey methods. It is to ascertain community member, physician, resident and medical student perspectives regarding Human Papillomavirus (HPV) infection, associated diseases and to identify barriers which prevent these groups from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection.

The research is focused on these questions:

Do community members understand the ease of transmission of the HPV virus in males 9-26? Do community members, physicians, residents and medical students have knowledge of the associated diseases that may occur with the HPV virus infection in males age 9-26? Do community members, physicians, residents and medical students know the ages in which males should receive the HPV vaccine three-shot series? What barriers prevent community members and physicians, residents and medical students from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection?

Condition or Disease Intervention/Treatment Phase
  • Other: Survey

Detailed Description

This is a minimal risk, anonymous, convenience sample, social behavioral study using qualitative descriptive survey methods. It is to ascertain community member, physician, resident and medical student perspectives regarding Human Papillomavirus (HPV) infection, associated diseases and to identify barriers which prevent these groups from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection.

The research is focused on these questions:

Do community members understand the ease of transmission of the HPV virus in males 9-26? Do community members, physicians, residents and medical students have knowledge of the associated diseases that may occur with the HPV virus infection in males age 9-26? Do community members, physicians, residents and medical students know the ages in which males should receive the HPV vaccine three-shot series? What barriers prevent community members and physicians, residents and medical students from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection?

Study Design

Study Type:
Observational
Actual Enrollment :
386 participants
Observational Model:
Ecologic or Community
Time Perspective:
Retrospective
Official Title:
Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination
Study Start Date :
Jul 1, 2016
Actual Primary Completion Date :
Mar 1, 2017
Actual Study Completion Date :
Apr 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Community Group Survey

Community members coming into the University Health Shreveport Ambulatory Care Facility.

Other: Survey
Clinical Faculty and community will be given a survey to define issues preventing HPV Vaccination

Physician Group Survey

Physicians affiliated with LSU Health Shreveport School of Medicine

Other: Survey
Clinical Faculty and community will be given a survey to define issues preventing HPV Vaccination

Outcome Measures

Primary Outcome Measures

  1. Barriers to HPV Vaccination [60 days]

    What are the barriers which prevent community members and physicians, residents and medical students from ensuring that males age 9-26 are vaccinated with the HPV three-shot vaccination.

Secondary Outcome Measures

  1. Knowledge pertaining to ease of Human Papillomavirus transmission. [60 days]

    Do community members and physicians understand the ease of HPV transmission?

  2. Knowledge of Associated HPV diseases [60 days]

    Do community member and physicians know the associated HPV diseases?

  3. Knowledge of age in which males should be vaccinated against HPV. [60 days]

    Do community member and physicians know the age in which males should be vaccinated against HPV?

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes

Community Participants

Inclusion

All visitors to the Pediatric or Internal Medicine University Health Shreveport Clinics willing to complete a survey

Community Study Exclusion

Those do not wish to participate in the study

Those who English is not their first language

Clinical Faculty, Resident, and Medical Student Study

Inclusion

All Louisiana State University Shreveport Health Clinical Faculty, Resident, and Medical Student Inclusion willing to to complete the online survey.

Clinical Faculty, Resident, and Medical Student Study

Exclusion

Any LSU Health Shreveport Clinical Faculty, Resident, and Medical Student which declines to take the survey or do not attempt to complete it.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Louisiana State University Health Shreveport Louisiana United States 71103

Sponsors and Collaborators

  • Louisiana State University Health Sciences Center Shreveport

Investigators

  • Principal Investigator: Julia M Esparza, MLS, 3186754179

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Julia M. Esparza, Head, User Education and Outreach Services, Louisiana State University Health Sciences Center Shreveport
ClinicalTrials.gov Identifier:
NCT02897232
Other Study ID Numbers:
  • STUDY00000618
First Posted:
Sep 13, 2016
Last Update Posted:
Feb 10, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Julia M. Esparza, Head, User Education and Outreach Services, Louisiana State University Health Sciences Center Shreveport
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 10, 2021